Michal Graff, MSc

CMC consultant

Pharmaceutical and medical device production specialist. Former CTO of Elastagen, an Australian class 3 medical device company for tissue repair products based on the human protein tropoelastin, acquired by Allergan Feb 2018. Instrumental in leading to the acquisition and subsequently directed the tech transfer. Accomplished Engineer with significant experience in all aspects of pharmaceutical / medical device production, research, scale up and design. B.Sc. Chemical engineering, M.Sc. Material engineering.

phone icon Whatsapp icon